Estradiol Cypionate
1 NDC across 1 manufacturer|0 Generic,1 Brand
Estradiol Cypionate is used to treat breast neoplasms, hot flashes, hypogonadism, premature menopause, menorrhagia and primary ovarian insufficiency, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product the first generic was approved Jan 1, 1982. In 2024, Medicare Part D spent $670K on Estradiol Cypionate across 3,076 claims for 1,595 beneficiaries.
Estradiol Cypionate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $51.91 to $51.91 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$51.91 – $51.91
per ML
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Pharmacia & Upjohn Company LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Estrogen class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing ESTRADIOL CYPIONATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DEPO-ESTRADIOL 5 MG/ML VIAL | $51.9084 per ML | — |
Frequently Asked Questions
What is Estradiol Cypionate used to treat?
Estradiol Cypionate is used to treat breast neoplasms, hot flashes, hypogonadism, premature menopause, menorrhagia and primary ovarian insufficiency, per the National Library of Medicine's MED-RT classification.
When did Estradiol Cypionate become available as a generic?
FDA approved the first generic Estradiol Cypionate (ANDA) on Jan 1, 1982.
How much does Medicare spend on Estradiol Cypionate?
In 2024, Medicare Part D spent $670K on Estradiol Cypionate across 3,076 claims for 1,595 beneficiaries.
How many Estradiol Cypionate products are on the market?
The Estradiol Cypionate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Estradiol Cypionate?
NADAC reference prices for Estradiol Cypionate range from $51.9084 to $51.9084 per ML.
Which manufacturers make Estradiol Cypionate?
1 manufacturer lists Estradiol Cypionate in NADAC. Ranked by number of NDCs, the largest are Pharmacia & Upjohn Company LLC (1).